Grants: Glaucoma
Page Content
ADAGES III: Contribution of Genotype to Glaucoma Phenotype in African Americans
- Weinreb Robert N., M.D.
- NIH / NEI
African Descent and Glaucoma Evaluation (ADAGES) IV: Alterations of the Lamina Cribrosa in Progression
- Zangwill Linda M., Ph.D.
- NIH
Age-Related Alterations in 5-Hydroxymethyl Cytidine Levels and Their Impact on Human Physiology
- Skowronska-Krawczyk, Dorota, M.Sc., Ph.D.
- Center for Healthy Aging, UC San Diego
- Center for Healthy Aging Research Pilot Award
Characterization of the Role of Dual Leucine Zipper Kinase (DLK) in Structural and Functional Retinal Ganglion Cell Loss in Rodent Models of Optic Neuropathy
- Welsbie Derek S., M.D., Ph.D.
- Fight For Sight Foundation
Collaboration on the Development of an Inhibitor of Dual Leucine Zipper Kinase (DLK) and Leucine Zipper Kinase Consortium
- Welsbie Derek S., M.D., Ph.D.
Diagnosis and Monitoring of Glaucoma with Optical Coherence Tomography Angiography
- Weinreb Robert N., M.D.
- NIH / NEI
Diagnostic Innovations in Glaucoma Study (DIGS): High Myopia and Advanced Diseases
- Zangwill Linda M., Ph.D.
- NIH
Dietary Interventions to Improve Vision UC San Diego
- Zangwill Linda M., Ph.D.
- Krupp Endowment Fund (KEF) Research Awards
Effects of a Single Osteopathic Manipulative Treatment (OMT) in Intraocular Pressure (IOP)
Eliminate to Protect
- Skowronska-Krawczyk Dorota, M.Sc., Ph.D.
- Glaucoma Research Foundation
Glaucoma Neuroprotection: Rho-Associated Kinase 2 (ROCK2) as an Upstream Activator of Dual-Leucine Zipper Kinase (DLK) in Response to Axonal Injury
- Welsbie Derek S., M.D., Ph.D.
- Ziegler Foundation Career Development Award
Kinase Multitargeting for Glaucoma Neuroprotection
- Welsbie Derek S., M.D., Ph.D.
- NIH
Machine Learning Methods for Detecting Disease-Related Functional and Structural Change in Glaucoma
- Bowd Christopher, Ph.D.
- NIH
Mitochondrial Dysfunction in Glaucomatous Optic Neuropathy
Mitochondrial Dysfunction in Glaucomatous Optic Neuropathy
- Ju Wonkyu, Ph.D.
- UC San Diego Academic Senate
Molecular Mechanism of Glaucoma
- Skowronska-Krawczyk Dorota, M.Sc. Ph.D.
- NIH
Nanoparticle-Based Glaucoma-Targeted Gene Therapy: A New Look at the Therapy for People who are Losing their Sight Ability
- Skowronska-Krawczyk Dorota, M.Sc.
- Ph.D. Eppley Foundation
Novel AAV/CRISPR Therapeutic for DLK Inhibition
- Welsbie Derek S., M.D., Ph.D.
- Brightfocus Foundation Glaucoma Research Award
Ocular Hypertension Treatment Study 20-Year Follow-Up: Clinic Center
- Weinreb Robert N., M.D.
- NIH / NEI
Ocular Hypertension Treatment Study 20-Year Follow-Up: Resource Center For The UC San Diego Optical Coherence Tomography Reading Center
- Zangwill Linda M., Ph.D.
- NIH
Ophthalmology and Visual Sciences Career Development K12 Program
- Weinreb Robert N., M.D.
- NIH / NEI
Optical Coherence Tomography in the Ocular Hypertension Treatment Study
- Zangwill Linda M., Ph.D.
- Zeiss
Personalized Forecasting of Disease Trajectory for Patients with Open Angle Glaucoma
- Zangwill Linda M., Ph.D.
- NIH
Targeting Dual Leucine Zipper Kinase as a Therapeutic Strategy for Traumatic Optic Neuropathy and Brain Injury
- Welsbie Derek S., M.D., Ph.D.
- Department of Defense Vision Research Program Translational Research Award
The Role of Microvasculature in the Pathophysiology of Glaucoma
- Zangwill Linda M., Ph.D.
- Brightfocus Foundation
Understanding Senescence to Develop Glaucoma Treatments
- Skowronska-Krawczyk Dorota, M.Sc., Ph.D.
- Research To Prevent Blindness
Unrestricted and Challenge Grant
- Weinreb Robert N., M.D.
- Research To Prevent Blindness
Show additional content areas below
ContentA1